Ethos Technologies Inc. - Class A (LIFE) analyst actions
Rating and price-target actions on LIFE in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the LIFE overview →
1 measured LIFE analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Ethos Technologies Inc. (LIFE) And Encourages Stockholders to Reach Out | Press release | +0.23% | -3.61% |
Keep exploring
More LIFE: earnings → · SEC filings → · LIFE overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ABATTIS BIOCEUTICALS ORD (ATTBF) | 83 | -0.24% | 41% |
| Intercept Pharmaceuticals, Inc. (ICPT) | 83 | +0.09% | 68% |
| COLOPLAST AS SP/ADR (CLPBY) | 82 | +0.13% | 59% |
| BASILEA PHARM AG AKT SHS (BPMUF) | 81 | 0.00% | 8% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.